Antares Therapeutics Enters Agreement with Novartis to Develop First-in-Class Cancer Therapies
Antares Therapeutics has entered into a strategic collaboration with Novartis to discover, develop and commercialize small-molecule therapies for…
Nurix, Roche sign $700M BTK degrader deal
0001549595false06/06/20261600 Sierra Point ParkwayBrisbaneCalifornia00015495952026-06-062026-06-06 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________________ FORM 8-K ___________________________________________ CURRENT REPORT…
Novartis enters licensing agreement with UNP for peptide therapeutics
Novartis has signed a research partnership and licensing agreement with Unnatural Products (UNP) valued at up to $1.7bn…